ClinicalTrials.gg
Drug

Solifenacin clinical trials

Also written Vesicare and YM905.

studies test it
100
open now
9
in phase 3
25
first study started
2003

How each study uses solifenacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the solifenacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Nov 2004 · VESICARE · NDA 021518 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Solifenacin
38
solifenacin succinate
33
Vesikur
6
solifenacin succinate suspension
4
Vesitrim
3

Brand

Vesicare
48

Development codes

YM905
32
HGP1103
1

In one entry with another drug

Given together, or one or the other

tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)
2
tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)
2
Solifenacin with vaginal estrogen cream
2

Studies by the year they started

99 studies that test it; most in 2010 (13)

Studies that test solifenacin, by start year
YearStudies
20031
20044
20065
20075
20088
20096
201013
20117
201212
20137
20144
20152
20163
20183
20191
20201
20212
20226
20231
20244
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
14
Phase 2
8
Phase 3
25
Phase 4
37
No phase
15

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 49 · Other 51

Astellas Pharma Inc (26) · Astellas Pharma Europe B.V. (14) · Mansoura University (4) · Far Eastern Memorial Hospital (3) · Loyola University (3) · National Taiwan University Hospital (3) · University of Aarhus (2) · University of South Florida (2)

Often tested with

Tested in the same studies.

Mirabegron (19) · Tamsulosin (15) · Tolterodine (3) · Tadalafil (2) · EC905 (2) · Oxybutynin (2) · Estrogens (2) · Vitamin D (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test solifenacin, phase 3 first.

Studies

Open first, then newest update. How each study uses solifenacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 100

See all 100 studies that test solifenacin →

Given beside what is tested · 5 — solifenacin is usual care or a partner of the new treatment
As the comparator · 22 — what is tested is compared with solifenacin

Showing 20 of 22.

Codes

What other systems call solifenacin · ClinicalTrials.gg INT006592

  • MeSH (NLM) D000069464Solifenacin SuccinateConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) A8910SQJ1USOLIFENACINConfirmed FDA, NLM, Wikidata
  • RxNorm 322167One source FDA
  • Wikidata Q59575279solifenacinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C75284SolifenacinOne source FDA
  • DrugBank DB01591One source Wikidata

Also registered as solifenacin succinate (UNII KKA5DLD701 · RxNorm 476588).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.